Business

Radiopharm received approval for RAD 202 trial acceleration

Radiopharm received approval for RAD 202 trial acceleration

Radiopharm Theranostics LimitedSeptember 30, 20255
Radiopharm received approval for RAD 202 trial acceleration

About this update from Radiopharm Theranostics Limited

Radiopharm Theranostics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Radiopharm Theranostics Limited

More from Radiopharm Theranostics Limited

All Radiopharm Theranostics Limited news →